Related Experiment Videos
[Neurocognitive and pharmacological approach to specific learning disorders]
1Laboratorio para el estudio de las Funciones Cerebrales Superiores, Buenos Aires, Argentina. metchepareborda@janssen.com.ar
Revista De Neurologia
|April 25, 2000
Summary
Specific learning disorders involve targeted processing mechanisms, unlike general developmental disorders. Neuropsychological assessment and tailored treatments, including cognitive training and specific medications, are key to managing these conditions.
Area of Science:
- Neuropsychology
- Developmental Neuroscience
- Pharmacology
Background:
- Specific learning disorders (SLDs) are distinct from general developmental disorders, affecting specific cognitive processes.
- Understanding subtypes of SLDs is crucial for effective intervention.
Purpose of the Study:
- To outline the importance of neuropsychological assessment in diagnosing and understanding SLDs.
- To review the neuro-cognitive and behavioral approaches to managing SLDs.
- To discuss the role of pharmacological interventions tailored to specific SLD subtypes.
Main Methods:
- Review of the DSM-IV classification for learning disorders.
- Emphasis on neuro-cognitive approaches integrating cognitive-behavioral strategies and computerized training.
- Analysis of pharmacological treatments based on neuropsychological profiles.
Main Results:
- Neuropsychological assessment is vital for identifying clinical subtypes of SLDs.
- A combined approach of cognitive training and behavioral strategies is recommended.
- Specific medications are discussed for various SLD subtypes, including ADHD, dyslexia, dysphasia, and dysgraphia.
Conclusions:
- Tailored treatment strategies, combining neuropsychological assessment, cognitive-behavioral approaches, and targeted pharmacotherapy, are essential for managing specific learning disorders.
- The neuro-cognitive framework provides a basis for understanding and treating the diverse manifestations of SLDs.